Yet another pot stock is poised to hit the U.S. market as Aphria Inc. indicated its intention to list on the New York Stock Exchange on Thursday.
The Leamington, Ont.-based cannabis producer submitted a Form 40-F to the U.S. Securities and Exchange Commission on Thursday, a filing that is made when a Canadian domiciled company announces its intention to offer its shares on the U.S. market.
“Aphria will provide additional details, including an anticipated trading date and NYSE ticker symbol, as soon as they become available and all requisite approvals are received,” said spokesperson David Ryan in an email to BNN Bloomberg.
The filing comes the same day Aurora Cannabis Inc. said it would begin trading on the NYSE next Tuesday after the exchange certified its approval for listing. The two companies will then join some of their peers on the U.S. market including Canopy Growth Corp., which also trades on the NYSE, and Cronos Group, which trades on the NASDAQ.
The move for some pot companies to list on U.S. exchanges could draw significant interest from U.S. institutional investors who have so far steered clear of investing in cannabis companies listed on Canadian markets.